Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Mandi, Germain ^a   Mockenhaupt, Frank P ^b   Coulibaly, Boubacar ^a   Meissner, Peter ^c   Müller, Olaf ^c  

^a CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; ANTIMALARIAL AGENT; CARRIER PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BURKINA FASO; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GASTROENTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RURAL AREA; TREATMENT INDICATION; TREATMENT OUTCOME; URBAN AREA; AMINO ACID SUBSTITUTION; ANIMAL; COMPARATIVE STUDY; DRUG RESISTANCE; GENETIC SELECTION; GENETICS; GENOTYPE; INFANT; ISOLATION AND PURIFICATION; PARASITEMIA; POINT MUTATION; POLYMERASE CHAIN REACTION; RURAL POPULATION; URBAN POPULATION;

AMINO ACID SUBSTITUTION; AMODIAQUINE; ANIMALS; ANTIMALARIALS; BURKINA FASO; CHILD, PRESCHOOL; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; PARASITEMIA; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; RURAL POPULATION; SELECTION (GENETICS); URBAN POPULATION;

EID: 43149085309     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-58     Document Type: Article

References (52)

1. Malaria. BM Greenwood K Bojang CJM Whitty GAT Targett, Lancet 2005 365 1487 1498 10.1016/S0140-6736(05)66420-3 15850634
2. The public health impact of chloroquine resistance in Africa. JF Trape, Am J Trop Med Hyg 2001 64 supplement 12 17 11425173
3. Combating malaria in Africa. JF Trape G Pison A Spiegel C Enel C Rogier, Trends Parasitol 2002 18 224 230 10.1016/S1471-4922(02)02249-3 11983604
4. Averting a malaria disaster. NJ White F Nosten S Looareesuwan WM Watkins K Marsh RW Snow G kokwaro J ouma TT Hien ME Molyneux TE Taylor CI Newbold TK Ruebush 2nd M Danis BM Greenwood RM Anderson P Olliaro, Lancet 1999 353 1965 1967 10.1016/S0140-6736(98)07367-X 10371589
5. Modelling a predictable disaster: the rise and spread of drug-resistant malaria. IM Hastings U D'Alessandro, Parasitol Today 2000 16 340 347 10.1016/S0169-4758(00)01707-5 10900482
6. Combination therapy for malaria in Africa: hype or hope? PB Bloland M Ettling S Meek, Bull World Health Organ 2000 78 1378 1388 11196485
7. Combination therapy for malaria. F Nosten P Brasseur, Drugs 2002 62 1315 1329 10.2165/00003495-200262090-00003 12076181
8. Antimalaria combinations. PG Kremsner S Krishna, Lancet 2004 364 285 294 10.1016/S0140-6736(04)16680-4 15262108
9. The benefits of artemisinin combination therapy for malaria extend beyond the individual patient. P Garner PM Graves, PLoS Med 2005 2 e105 15839750 10.1371/journal.pmed.0020105
10. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. G Dorsey D Njama M Kamya A Cattamanchi D Kyabayinze S Staedke A Gasasira P Rosenthal, Lancet 2002 360 2031 2038 10.1016/S0140-6736(02)12021-6 12504399
11. Efficacy of chloroquine, amodiaquine, suphadoxine-pyrimethamine and combination therapy with artesunate in Mosambican children with non-complicated malaria. F Abacassamo S Enosse JJ Aponte FX Gómez-Olivé L Quintó S Mabunda A Barreto P Magnussen AM Rønn R Thompson PL Alonso, Trop Med Int Health 2004 9 200 208 10.1046/j.1365-3156.2003.01182.x 15040556
12. Artesunate combinations for treatment of malaria: meta-analysis. International Artemisinin Study Group, Lancet 2004 363 9 17 10.1016/S0140- 6736(03)15162-8 14723987
13. Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallet J Ahmed C Drakeley B Greenwood C Whitty, Lancet 2005 365 1474 1480 10.1016/S0140-6736(05)66417-3 15850631
14. Supervised versus unsupervised intake of six-dose atremether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. P Piola C Fogg F Bajunirwe S Biraro F Grandesso E Ruzagira J Babigumira I Kigozi J Kiguli J Kyomuhendo, Lancet 2005 365 1467 1473 10.1016/S0140-6736(05)66416-1 15850630
15. Two fixed dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. A Ratcliff H Siswantoro E Kenangalem R Maristela R Wuwung F Laihad E Ebsworth N Anstey E Tjitra R Price, Lancet 2007 369 757 765 10.1016/S0140-6736(07)60160-3 17336652
16. Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. I Van den Broek R Amsalu M Balasegaram P Hepple E Alemu EB Hussein M Al-Faith J Montgomery F Checchi, Malar J 2005 4 14 15730557 10.1186/1475-2875-4-14
17. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. CJ Sutherland R Ord S Dunyo M Jawara CJ Drakeley N Alexander R Coleman M Pinder G Walraven GAT Targett, PLoS Med 2005 2 e92 15839740 10.1371/journal.pmed.0020092
18. Artemether-lumifantrine versus artesunate-amodiaquine for treatment of uncomplicated childhood malaria in Nigeria: randomised controlled trial. M Meremikwu A Araribe R Ejemat A Oyo-Ita J Ekenjohu C Nwachukwu D Ordu E Ezedinachi, Malar J 2006 5 43 16704735 10.1186/1475-2875-5-43
19. Artemether lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. I Zongo G Dorsey N Rouamba H Tinto C Dokomajilar R Guiguemde P Rosenthal J Ouedraogo, Lancet 2007 369 491 498 10.1016/S0140- 6736(07)60236-0 17292769
20. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether/lumifantrine in eastern Sudan. EA Mukhtar NB Gadella SEG El-Zaki I Mukhtar FA Mansour A Babiker BB El-Sayed, Malar J 2007 6 92 17631681 10.1186/1475-2875-6-92
21. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. B Faye JL Ndiaye D Ndiaye Y Dieng O Faye O Gaye, Malar J 2007 6 80 17570848 10.1186/1475-2875-6-80
22. Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. D Ménard NNH Andrianina Z Ramiandrasoa A Randriamauantena N Rasoarilaloa M Jahevitra A Ratsimbasoa L Tuseo A Ravelosan, Malar J 2007 6 65 17519010 10.1186/1475-2875-6-65
23. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers for resistance to sulphadoxine-pyrimethamine in N'Zérékoré M Bonnet C Roper M Félix L Coulibaly GM Koukolougo JI Guthmann, Malar J 2007 6 54 17477865 10.1186/1475-2875-6-54
24. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. I Van den Broek C Kitz S Al Attas F Libama M Balasegaram JP Guthmann, Malar J 2006 5 113 17125496 10.1186/1475-2875-5-113
25. Comparative efficacy of amodiaquine-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. AF Gasasira G Dorsey B Nzarubara SG Staedke A Nassali PJ Rosenthal MR Kamya, Am J Trop Med Hyg 2003 68 127 32 12641399
26. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. CE Rwangacondo F Niyitegeka J Sarushi F Niyitegeka J Sarushi C Karema V Mugisha J Dujardin CV Overmeir J Van den Ende U D'Alessandro, Am J Trop Med Hyg 2003 68 743 747 12887037
27. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. I Zongo G Dorsey N Rouamba C Dokomajilar M Lankoande J Ouedraogo PJ Rosenthal, Am J Trop Med Hyg 2005 73 826 832 16282288
28. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. A Yeka K Banek N Bakyaita SG Staedke MR Kamya A Talisuna F Kironde SL Nsobya A Kilian M Slater A Reingold PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Med 2005 2 e190 16033307 10.1371/journal.pmed.0020190
29. Year surveillance of drug resistant malaria in Burkina Faso (1982-1991). TR Guigemdé A Aoba JB Ouedrago L Lamizana, Am J Trop Med Hyg 1994 50 699 704 8024062
30. Clinical efficacy of chloroquine in young children with uncomplicated malaria - a community based study in rural Burkina Faso. O Müller C Traoré B Kouyaté Trop Med Int Health 2003 8 202 203 10.1046/j.1365-3156.2003.01018.x 12631308
31. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. P Meissner G Mandi S Witte B Coulibaly U Mansmann J Rengelshausen W Schiek A Jahn M Sanon T Tapsoba I Walter-Sack G Mikus J Burhenne K Riedel H Schirmer B Kouyate O Müller, Malar J 2005 4 46 16179089 10.1186/1475-2875-4-45
32. Marked differences in the prevalence of chloroquine resistance between urban and rural communities in Burkina Faso. P Meissner G Mandi F Mockenhaupt S Witte B Coulibaly U Mansmann C Frey RH Schirmer O Müller, Acta Trop 2007 105 1 81 6 10.1016/j.actatropica.2007.07.014 17904509
33. A randomized trial of chloroquine, amodiaquine, and pyrimethamine- sulfadoxine in Gambian children with uncomplicated malaria. O Müller M Boele van Hensbroek S Jaffar C Drakeley C Okorie D Joof M Pinder B Greenwood, Trop Med Int Health 1996 1 124 132 10.1046/j.1365-3156.1996.d01-13.x 8673817
34. Systematic review of amodiaquine treatment in uncomplicated malaria. P Olliaro C Nevill J LeBras P Ringwald P Mussano P Garner P Brasseur, Lancet 1996 348 1196 1201 10.1016/S0140-6736(96)06217-4 8898036
35. Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. P Brasseur R Guiguemde S Diallo V Guiyedi M Kombila P Ringwald P Olliaro, Trans R Soc Trop Med Hyg 1999 93 645 650 10.1016/S0035-9203(99)90083-4 10717757
36. A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. H Barennes N Nagot I Valea T Koussoube-Balima A Ouedraogo T Sanou A Ouedraogo, Trop Med Int Health 2004 9 438 444 10.1111/j.1365-3156.2004.01224.x 15078261
37. The great failure of malaria control in Africa: a district perspective from Burkina Faso. B Kouyaté A Sie M Yé M De Allegri O Müller, PLoS Med 2007 4 e127 17550300 10.1371/journal.pmed.0040127
38. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. P Meissner G Mandi B Coulibaly S Witte T Tapsoba U Mansmann J Rengelshausen W Schiek A Jahn I Walter-Sack G Mikus J Burhenne KD Riedel H Schirmer B Kouyaté O Müller, Malar J 2006 5 84 17026773 10.1186/1475-2875-5-84
39. Effect of zinc supplementation on malaria morbidity among West African children: a randomized double-blind placebo-controlled trial. O Müller H Becher A Baltussen Y Ye D Diallo M Konate A Gbangou B Kouyate M Garenne, BMJ 2001 322 1567 1572 10.1136/bmj.322.7302.1567 11431296
40. Efficacy of pyrimethamine-sulfadoxine in young children with falciparum malaria in rural Burkina Faso. O Müller C Traoré B Kouyaté Malar J 2004 3 10 15134583 10.1186/1475-2875-3-10
41. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, WHO/HTM/RBM 2003 50
42. A molecular marker for chloroquine-resistant falciparum malaria. A Djimdé OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourté A Dicko XZ Su T Nomura DA Fidock TE Wellems CV Plowe D Coulibaly, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
43. Chloroquine-treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86. FP Mockenhaupt S Ehrhardt TA Eggelte P Agana-Nsiire K Stollberg A Mathieu M Markert RN Otchwemah U Bienzle, Ann Trop Med Parasitol 2005 99 723 732 10.1179/136485905X75395 16297285
44. Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. EO Ochong IV van den Broek K Keus A Nzila, Am J Trop Med Hyg 2003 69 184 187 13677373
45. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. G Holmgren JP Gil PM Ferreira MI Veiga CO Obonyo A Björkman, Infect Genet Evol 2006 6 309 314 10.1016/j.meegid.2005.09.001 16271310
46. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso. C Dokomajilar ZM Lankoande G Dorsey I Zongo JB Ouedraogo PJ Rosenthal, Am J Trop Med Hyg 2006 75 162 165 16837725
47. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. G Holmgren J Hamrin J Svärd A Mårtensson JP Gil A Björkman, Infect Genet Evol 2007 7 562 569 10.1016/j.meegid.2007.03.005 17467344
48. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. G Snounou X Zhu N Siripoon W Jarra S Thaithong KN Brown S Viriyakosol, Trans R Soc Trop Med Hyg 1999 93 369 374 10.1016/S0035-9203(99)90120-7 10674079
49. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. B Greenhouse C Dokomajilar A Hubbard PJ Rosenthal G Dorsey, Antimicrob Agents Chemother 2007 51 3096 3103 17591848 10.1128/AAC.00159-07
50. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. GS Humphreys I Merinopoulos J Ahmed CJ Whitty TK Mutabingwa CJ Sutherland RL Hallett, Antimicrob Agents Chemother 2007 51 991 997 17194834 10.1128/AAC.00875-06
51. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan. N Durrani T Leslie S Rahim K Graham F Ahmad M Rowland, Trop Med Int Health 2005 10 521 529 10.1111/j.1365-3156.2005.01429.x 15941414
52. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. A Zoungrana B Coulibaly A Sie I Walter-Sack FP Mockenhaupt B Kouyate RH Schirmer C Klose U Mansmann P Meissner O Müller, PLoS One 2008 3 e1630 18286187 10.1371/journal.pone.0001630